This stock is ready for move in higher territory as it confirm double bottom. followed by awsome volume and 20 MA at weekly time frame.
This stock has a heavy subscription during its ipo.
buy above today candle sl will be weekly candle low.
i am not giving level of entry and sl so that u can learn how to put sl.
foe me its a cup and handle pattern, even measurements are not marching
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.
The Co. has a...
Stock name = Supriya Lifescience Limited.
Weekly chart setup
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined.
Master Score - C
Disclaimer: This is for demonstration and educational purpose only. this is not buying and selling...
NSE:SUPRIYA has formed clear bullish structure and taken solid bounce from support 237-250 zone.
Buy Level is 283. We can see long term move above 300 with SL of 260 if it give pullback buy more near 280 to 290 range.
Major targets levels are highlighted in blue lines.
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.
Supriya makes gud consolidation on same price range also makes gud price action. Also done break out with gud volume. it will be a gud buy with
Sl of 230
First target will be 387
Breakout post a long consolidation. Now consolidating near the breakout level/support. The stock has already transformed into stage 2 and will continue the momentum in the coming days.
supriya lifescience is a good company, with a good fundamentals and increasing profits. lastly it has a good profit margin too.
pharma sector is a most toughest sector to analyse.
still with a help of technicals and price action we can make it easier.
targets are mentioned, the stock is following certaining support levels, no movement in the stock for certain...
cmp 528
trgt swing 5-10%
long term 2X
sl 466
Disclaimer:
All information shared is just for educational purposes.
By no means shall we be accountable for any debits/losses amounting out of it.
We are not SEBI registered Analysts, so please consult your Investment Advisor and take rational decisions.
